VX-993   Click here for help

GtoPdb Ligand ID: 13683

Synonyms: VX993
Approved drug
VX-993 is an approved drug
Compound class: Synthetic organic
Comment: VX-993 is an orally bioavailable NaV1.8 ion channel inhibitor [1]. NaV1.8 is a validated target for the development of non-opioid analgesics.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 8
Topological polar surface area 100.38
Molecular weight 490.42
XLogP 0.94
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@H]1[C@@H](C2=CC=C(C(=C2OC)F)F)[C@H](C(=O)NC3=CC=C([C@H](CO)O)N=C3)O[C@@]1(C)C(F)(F)F
Isomeric SMILES C[C@H]1[C@H]([C@@H](O[C@@]1(C)C(F)(F)F)C(=O)NC2=CN=C(C=C2)[C@H](CO)O)C3=C(C(=C(C=C3)F)F)OC
InChI InChI=1S/C22H23F5N2O5/c1-10-16(12-5-6-13(23)17(24)18(12)33-3)19(34-21(10,2)22(25,26)27)20(32)29-11-4-7-14(28-8-11)15(31)9-30/h4-8,10,15-16,19,30-31H,9H2,1-3H3,(H,29,32)/t10-,15-,16-,19+,21+/m0/s1
InChI Key HXXNLIYFNQKZHX-PEHJGKTGSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
VX-993 has progressed to clinical evaluations, to determine safety and efficacy as a treatment for pain disorders.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT06619847 A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy Phase 2 Interventional Vertex Pharmaceuticals Incorporated
NCT06619860 Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy Phase 2 Interventional Vertex Pharmaceuticals Incorporated